CONTROL BIONICS

Control Bionics is an Australian medical device company specializing in augmentative and alternative communication (AAC) technologies and assistive devices for individuals with speech impairment, paralysis, and movement limitations. The company develops wearable biosensor systems and speech-generating devices that enable users with degenerative neurological conditions, spinal cord injuries, cerebral palsy, and similar disorders to communicate and control external devices through bioelectric signals or spatial eye-gaze control. Core products include the NeuroNode Trilogy and Duo systems (speech-generating devices with wireless wearable sensors), EyeGaze Duo (eye-tracking communication system), UnoTouch (portable control device), and NeuroStrip (miniaturized EMG sensor for physiological monitoring). The company also develops solutions for sports performance optimization and physical rehabilitation applications. Control Bionics serves clinical, home care, and athletic markets across Australia, North America, and internationally.